Su-Leng Tan Lee Discloses Investment at BioNexus Gene Lab Corp with 11.5% StakeTradingView·Aug 14 at 04:36 PMBGLC0.00%
BioNexus Q2 FY26 net loss narrows 53.51% to $286,451; revenue drops 96.63% to $76,156 vs year-ago quarterPUBT·Aug 14 at 04:07 PMBGLC0.00%
BioNexus Gene Lab files initial beneficial ownership statement for Fidelion Diagnostics Pte. LtdPUBT·Aug 7 at 03:28 PMBGLC0.00%
BioNexus Gene Lab names CFO Chong Set Fui in initial beneficial ownership filingPUBT·Jul 31 at 04:01 PMBGLC0.00%
BioNexus advances VitaGuard Southeast Asia rollout after China hospital visitsPUBT·Jul 28 at 08:00 AMBGLC0.00%
12 Industrials Stocks Moving In Tuesday's Pre-Market Sessionbenzinga_article·Jul 28 at 07:05 AMWETO+2.61%SPWRW+14.00%
U.S. stock market midday update: BGLC up 15.88% without positive news? Capital inflow drives volatilityPrice Alert·Jun 15 at 11:17 AMBGLC0.00%
Genflow Biosciences PLC Announces Total Voting RightsMorningStar·Mar 31 at 01:55 AMBGLC0.00%IDNA+4.56%
BioNexus Gene Lab Corp. Completes Chemrex Governance Restructuring; Appoints Matthew Barsing as ChairmanUnusual Whales·Mar 24 at 05:06 PMPBE+1.42%BBH+1.28%
